Grai Andreason

Title: Grai Andreason: Innovator in Vascular Biology

Introduction

Grai Andreason is a notable inventor based in La Jolla, California. She has made significant contributions to the field of vascular biology, particularly through her innovative work on vascular endothelial growth factor (VEGF). Her research has implications for the treatment of cardiovascular diseases.

Latest Patents

Grai Andreason holds a patent for novel forms of the angiogenic factor vascular endothelial cell growth factor, specifically VEGF. This patent discloses new forms of human VEGF-A that contain and do not contain exon 6. Additionally, it includes novel forms of VEGF-A that contain exon 6 along with other variations. These novel VEGF proteins have potential applications in treating cardiovascular diseases by stimulating vascular cell proliferation and enhancing endothelial cell growth and vascular permeability. The invention also encompasses nucleic acids encoding these novel VEGF proteins, as well as methods of treatment utilizing these nucleic acids.

Career Highlights

Grai Andreason has established herself as a key figure in her field through her innovative research and patent contributions. Her work has been instrumental in advancing the understanding of vascular biology and its applications in medicine.

Collaborations

Grai collaborates with Andrew J. Baird, contributing to the advancement of research in vascular biology and related fields.

Conclusion

Grai Andreason's contributions to the field of vascular biology through her patent on VEGF highlight her role as an innovator. Her work continues to influence the treatment of cardiovascular diseases and showcases the importance of research in this critical area of health.